Correction to: Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda

Malar J. 2022 Feb 7;21(1):37. doi: 10.1186/s12936-022-04049-1.

¹ Infectious Diseases Research Collaboration, Kampala, Uganda. [email protected].
² Infectious Diseases Research Collaboration, Kampala, Uganda.
³ USAID's Malaria Action Program for Districts, Kampala, Uganda.
⁴ National Malaria Control Division, Ministry of Health Uganda, Kampala, Uganda.
⁵ U.S. President's Malaria Initiative, Kampala, Uganda.
⁶ Malaria Branch, Centers for Disease Control and Prevention & President's Malaria Initiative, Atlanta, GA, USA.
⁷ Makerere University College of Health Sciences, Kampala, Uganda.

No abstract available

Publication types